Salesforce
CRM
$185.95
+1.05%
Salesforce, Inc. is a leading provider of enterprise cloud computing solutions, offering customer relationship management (CRM) technology and a comprehensive Customer 360 platform that integrates sales, service, marketing, and commerce applications. As a dominant player in the CRM and enterprise software market, Salesforce differentiates itself through its broad product ecosystem, including MuleSoft for data integration and the Salesforce Platform for custom app development. The current investor narrative centers on the company's strategic pivot to AI, particularly its Agentforce platform, which recently secured a $1.6 billion federal AI contract, signaling strong demand and validating its AI growth story. However, the stock has faced significant pressure due to broader tech sector selloffs, inflation concerns, and a rotation away from software into hardware, creating a debate about whether the AI-driven growth potential justifies the current valuation.…
CRM
Salesforce
$185.95
Related headlines
Investment Opinion: Should I buy CRM Today?
Rating & Thesis: We rate CRM as a Buy, driven by its attractive forward valuation (PE 11.86x) and the potential for AI-driven growth to reaccelerate revenue. The analyst consensus is 'Buy' with an average target of $241.72, implying 31.4% upside. The core thesis is that the market is overly pessimistic, and the $1.6 billion AI contract validates the Agentforce opportunity.
Sign up to view all
CRM 12-Month Price Forecast
The AI-driven growth story is compelling, with the recent contract win providing tangible evidence of demand. The valuation is attractive on forward earnings, and the company's strong cash flow supports investment. However, the medium confidence reflects the uncertainty around AI monetization and macro headwinds. If the company can sustain revenue growth above 13% and show margin expansion, the stock could re-rate higher. Conversely, if AI adoption stalls or macro pressures persist, the stock could remain range-bound. We would upgrade our stance if the company raises guidance or secures more large AI deals, and downgrade if growth decelerates below 10%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Salesforce's 12-month outlook, with a consensus price target around $241.72 and implied upside of +30.0% versus the current price.
Average Target
$241.72
0 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$160 - $475
Analyst target range
The target price range spans from a low of $160.00 to a high of $475.00, representing a wide spread of 197% between the low and high targets. This wide dispersion suggests significant uncertainty about Salesforce's future performance, with the high target of $475 likely assuming successful execution of its AI strategy, including Agentforce adoption and margin expansion, while the low target of $160 may reflect concerns about competitive pressures, macroeconomic headwinds, or a slowdown in enterprise software spending. Recent institutional ratings show a mix of upgrades and downgrades, with Guggenheim upgrading from Neutral to Buy and KeyBanc downgrading from Overweight to Sector Weight, indicating that analysts are reassessing the stock's prospects in light of the AI-driven growth narrative and market conditions. Overall, the consensus leans bullish, but the wide target range highlights the high level of uncertainty surrounding the stock's future trajectory.
Bulls vs Bears: CRM Investment Factors
Salesforce presents a mixed picture: strong fundamentals with accelerating revenue growth, robust margins, and a validated AI strategy, but a stock price that has been beaten down due to sector rotation and macro concerns. The bull case rests on the forward PE of 11.86x and the $1.6 billion AI contract, suggesting the market is undervaluing future earnings. The bear case highlights the persistent downtrend and the risk of continued software underperformance. Currently, the evidence slightly favors the bull case given the attractive valuation and growth catalysts, but the key tension is whether the AI-driven growth can overcome the macro headwinds and sector rotation. If Agentforce adoption accelerates and revenue growth sustains above 13%, the stock could re-rate higher; if not, it may test the 52-week low.
Bullish
- AI Contract Validates Agentforce: Salesforce secured a $1.6 billion federal AI contract, signaling strong demand for its Agentforce platform and validating its AI growth strategy. This win could lead to additional large enterprise deals, providing a tangible catalyst for revenue acceleration.
- Revenue Growth Accelerating: Q1 FY2027 revenue grew 13.27% YoY to $11.133 billion, up from 9.4% in the prior quarter, indicating a reacceleration in growth. This suggests the company is successfully navigating macro headwinds and gaining traction with its AI offerings.
- Undervalued on Forward Earnings: The forward PE of 11.86x is significantly lower than the trailing PE of 27.04x, implying the market expects substantial earnings growth. If the company delivers on analyst EPS estimates of $25.18, the stock could be undervalued, offering upside potential.
- Strong Profitability and Cash Flow: Operating margin is 21.47% and free cash flow TTM is $14.66 billion, demonstrating robust cash generation. This financial strength supports continued investment in AI and shareholder returns through buybacks and dividends.
Bearish
- Stock in Downtrend: CRM is down 28.77% over the past year and trades at 30.6% of its 52-week range, near the low of $146.32. The persistent downtrend reflects selling pressure and a lack of buyer conviction, which could continue if macro conditions worsen.
- Sector Rotation to Hardware: Recent news highlights a shift in enterprise tech spending from software to hardware, as evidenced by IBM's worst-ever stock drop. This rotation could continue to pressure software valuations, including Salesforce, despite its AI initiatives.
- High Valuation on Trailing Earnings: The trailing PE of 27.04x is above the market average, and the PEG ratio of 1.24 suggests the stock is not cheap on a growth-adjusted basis. If earnings growth disappoints, the stock could face multiple compression.
- Wide Analyst Target Range: Analyst targets range from $160 to $475, a 197% spread, indicating extreme uncertainty about the company's future. This dispersion suggests that the stock could be volatile and that the consensus target may not be reliable.
CRM Technical Analysis
Salesforce is currently in a pronounced downtrend, with the stock price at $184.02, down 28.77% over the past year. The price is trading at 30.6% of its 52-week range (between $146.32 low and $269.11 high), indicating it is near the lower end of its yearly range, which often suggests a potential value opportunity or a falling knife. The 52-week low of $146.32 was tested in June 2026, and while the stock has bounced off that level, it remains well below its 52-week high, reflecting persistent selling pressure and a lack of sustained buying interest.
Beta
1.15
1.15x market volatility
Max Drawdown
-45.1%
Largest decline past year
52-Week Range
$146-$269
Price range past year
Annual Return
-25.8%
Cumulative gain past year
| Period | CRM Return | S&P 500 |
|---|---|---|
| 1m | +11.9% | +1.7% |
| 3m | -0.6% | +4.7% |
| 6m | -6.8% | +10.4% |
| 1y | -25.8% | +21.9% |
| ytd | -26.7% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CRM Fundamental Analysis
Salesforce's revenue growth has been solid, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $11.133 billion, up 13.27% year-over-year. This growth rate is a slight acceleration from the previous quarter's 9.4% YoY growth (Q4 FY2026 revenue of $11.201 billion), indicating that the company is maintaining a healthy growth trajectory despite macroeconomic headwinds. The subscription and support segment, which accounts for the vast majority of revenue at $10.593 billion, continues to drive growth, while professional services contribute $540 million. The multi-quarter trend shows consistent revenue increases from $9.825 billion in Q1 FY2026 to $11.133 billion in Q1 FY2027, reflecting a stable and growing business.
Quarterly Revenue
$11.1B
2026-04
Revenue YoY Growth
+13.3%
YoY Comparison
Gross Margin
76.9%
Latest Quarter
Free Cash Flow
$14.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CRM Overvalued?
Given that Salesforce is profitable, the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 27.04x, while the forward PE is 11.86x, indicating that the market expects significant earnings growth in the coming year. This wide gap between trailing and forward PE suggests that analysts anticipate a substantial increase in earnings, likely driven by AI-related initiatives and operational efficiencies. The forward PE of 11.86x is notably lower than the trailing multiple, which could imply that the stock is undervalued relative to its future earnings potential, or that the market is pricing in a high level of growth that may be difficult to achieve.
PE
27.0x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 18x~247x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Salesforce's financial health is generally solid, but there are risks. The company has a debt-to-equity ratio of 0.29, which is manageable, but its current ratio of 0.76 indicates potential liquidity concerns, as current liabilities exceed current assets. This could be a red flag if cash flow deteriorates. Additionally, the company's reliance on subscription revenue (95% of total) makes it vulnerable to churn or slowdowns in enterprise spending. The operating margin of 21.47% is strong, but any significant investment in AI could pressure margins in the near term. The wide gap between trailing and forward PE (27x vs 11.9x) implies high earnings growth expectations; if these are not met, the stock could face de-rating.
FAQ
The key risks are: 1) Financial: The current ratio of 0.76 indicates potential liquidity issues, though the company generates strong cash flow. 2) Competitive: Intense competition from Microsoft and others could pressure market share. 3) Macro: Inflation and high interest rates could continue to compress software valuations. 4) Company-specific: Execution risks in AI monetization could lead to missed earnings expectations. The most severe risk is a continued sector rotation away from software, which could push the stock to its 52-week low of $146.32, a 20.5% downside from current levels.
The 12-month forecast is mixed but leans bullish. In the base case (45% probability), the stock could reach $200-$240, aligning with the analyst average target of $241.72. In the bull case (30% probability), it could reach $250-$300 if AI adoption accelerates. In the bear case (25% probability), it could fall to $146-$160 if growth decelerates or macro conditions worsen. The most likely scenario is the base case, assuming revenue growth stays around 13% and the company executes on its AI strategy.
CRM is undervalued on a forward basis, with a forward PE of 11.86x compared to the trailing PE of 27.04x, indicating the market expects significant earnings growth. The PEG ratio of 1.24 suggests the stock is reasonably priced relative to its growth rate. Compared to the software industry average forward PE of around 20x, CRM appears cheap. However, the trailing PE is above the market average, so the valuation is only attractive if the company delivers on its earnings growth expectations. The market is pricing in a high level of growth, but the recent AI contract win and revenue acceleration support this optimism.
CRM is a good buy for investors with a 12-month horizon who are comfortable with volatility. The stock is trading at a forward PE of 11.86x, which is attractive given the expected earnings growth, and the analyst consensus is 'Buy' with a 31.4% upside to the average target of $241.72. The main risk is continued sector rotation and macro headwinds, but the $1.6 billion AI contract and accelerating revenue growth provide a strong catalyst. For long-term investors, the AI opportunity could drive significant upside, but for short-term traders, the stock may remain volatile.
CRM is more suitable for long-term investment, given its growth stage and the potential for AI to drive multi-year growth. The stock's beta of 1.178 indicates higher volatility, making it less ideal for short-term trading. The company's strong cash flow and dividend yield of 0.79% provide some downside support, but the earnings visibility is moderate. A minimum holding period of 12 months is recommended to allow the AI narrative to play out and for the market to re-rate the stock. Short-term traders may find opportunities in the volatility, but the risk is high.